Inhibition of B cell receptor-mediated B cell activation by coengagement of CD19 and FcγRIIb with Fc-engineered antibodies

被引：0
|
作者：
Szymkowski, David E. [1 ]
Chu, Seung Y. [1 ]
Vostiar, Igor [1 ]
Horton, Holly M. [1 ]
Karki, Sher [1 ]
Moore, Gregory L. [1 ]
Lazar, Greg A. [1 ]
Pong, Erik [1 ]
Joyce, Patrick F. [1 ]
Desjarlais, John [1 ]
机构：
[1] Xencor Inc, Monrovia, CA USA
来源：
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S443 / S443
页数：1
相关论文
共 50 条
  • [1] Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcγRIIb with Fc-engineered antibodies
    Chu, Seung Y.
    Vostiar, Igor
    Karki, Sher
    Moore, Gregory L.
    Lazar, Greg A.
    Pong, Erik
    Joyce, Patrick F.
    Szymkowski, David E.
    Desjarlais, John R.
    MOLECULAR IMMUNOLOGY, 2008, 45 (15) : 3926 - 3933
  • [2] Inhibition of B Cell Receptor-Mediated B Cell Activation and IgE secretion by Coengagement of Surface IgE and FcγRIIb with Fc-Engineered Antibodies
    Szymkowski, D. E.
    Horton, H. H.
    Chu, S. Y.
    Zalevsky, J.
    Herman, H.
    Pong, E.
    Desjarlais, J. R.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (02) : AB118 - AB118
  • [3] Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody
    Chu, Seung Y.
    Horton, Holly M.
    Pong, Erik
    Leung, Irene W. L.
    Chen, Hsing
    Duc-Hanh Nguyen
    Bautista, Cristina
    Muchhal, Umesh S.
    Bernett, Matthew J.
    Moore, Gregory L.
    Szymkowski, David E.
    Desjarlais, John R.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (04) : 1102 - 1115
  • [4] Suppression of innate and adaptive B cell activation pathways by antibody coengagement of FcγRIIb and CD19
    Szili, Daniel
    Cserhalmi, Marcell
    Banko, Zsuzsanna
    Nagy, Gyoergy
    Szymkowski, David E.
    Sarmay, Gabriella
    MABS, 2014, 6 (04) : 991 - 999
  • [5] Through an ITIM-Independent Mechanism the FcγRIIB Blocks B Cell Activation by Disrupting the Colocalized Microclustering of the B Cell Receptor and CD19
    Xu, Liling
    Li, Gen
    Wang, Jing
    Fan, Yilin
    Wan, Zhengpeng
    Zhang, Shaosen
    Shaheen, Samina
    Li, Jing
    Wang, Li
    Yue, Cai
    Zhao, Yan
    Wang, Fei
    Brzostowski, Joseph
    Chen, Ying-Hua
    Zheng, Wenjie
    Liu, Wanli
    JOURNAL OF IMMUNOLOGY, 2014, 192 (11): : 5179 - 5191
  • [6] Fc-Engineered Antibodies with Enhanced Fc-Effector Function for the Treatment of B-Cell Malignancies
    van der Horst, Hilma J.
    Nijhof, Inger S.
    Mutis, Tuna
    Chamuleau, Martine E. D.
    CANCERS, 2020, 12 (10) : 1 - 24
  • [7] FC RECEPTOR PHOSPHORYLATION DURING RECEPTOR-MEDIATED CONTROL OF B-CELL ACTIVATION
    HUNZIKER, W
    KOCH, T
    WHITNEY, JA
    MELLMAN, I
    NATURE, 1990, 345 (6276) : 628 - 632
  • [8] Antibody-Mediated Coengagement of FcγRIIb and B Cell Receptor Complex Suppresses Humoral Immunity in Systemic Lupus Erythematosus
    Horton, Holly M.
    Chu, Seung Y.
    Ortiz, Elizabeth C.
    Pong, Erik
    Cemerski, Saso
    Leung, Irene W. L.
    Jacob, Noam
    Zalevsky, Jonathan
    Desjarlais, John R.
    Stohl, William
    Szymkowski, David E.
    JOURNAL OF IMMUNOLOGY, 2011, 186 (07): : 4223 - 4233
  • [9] FC RECEPTOR-MEDIATED INHIBITION OF MURINE B-LYMPHOCYTE ACTIVATION
    RYAN, JL
    HENKART, PA
    JOURNAL OF EXPERIMENTAL MEDICINE, 1976, 144 (03): : 768 - 775
  • [10] Recombinant Factor VIII Fc Inhibits B Cell Activation via Engagement of the FcγRIIB Receptor
    Georgescu, Maria T.
    Moorehead, Paul C.
    Liu, Tongyao
    Dumont, Jennifer
    Scott, David W.
    Hough, Christine
    Lillicrap, David
    FRONTIERS IN IMMUNOLOGY, 2020, 11
12345